Molecular Templates to Present at 2013 BIO International Convention
GEORGETOWN, Texas--(BUSINESS WIRE)-- Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapies, announced today that it will present at the upcoming 2013 BIO International Convention in Chicago, IL, on Tuesday, April 23rd, 2013.
Eric Poma, CEO and CSO, will present an overview of the company’s ongoing pre-clinical programs utilizing its novel platform for developing targeted biologics with unique biological properties.
“We look forward to sharing the company’s unique biologic platform for drug development with the BIO International audience,” said Eric Poma, CEO and CSO, Molecular Templates. “Our technology represents a new class of targeted therapeutics with predictable pharmacokinetics and unique functionalities. As we advance our candidates forward, we are excited about leveraging the broad utility of our technology for a variety of cancer types and settings.”
Event: 2013 BIO International Convention
Date: Tuesday, April 23rd, 2013
Time: 9:45 am (Central Time)
Location: Chicago Blackhawks Room; McCormick Place Convention Center; Chicago
About Molecular Templates
Molecular Templates is a venture-backed biopharmaceutical company focused on the discovery and development of a new class of targeted biologic therapeutics. The company is pursuing development of various leads across a wide range of cancers.
For more information, please visit www.moleculartemplates.com.
Molecular Templates, Inc.
Jason Kim, 512-639-0206
Source: Molecular Templates, Inc.
Released April 22, 2013